FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947033548> ?p ?o ?g. }

• W2947033548 abstract "6640 Background: Costs of cancer care may impact access to therapy, adherence, and distress among patients. However, the degree to which patients with metastatic breast cancer (MBC) wish to discuss financial issues when making treatment decisions is unknown. Methods: In a single arm feasibility trial, 40 women with newly diagnosed or progressive MBC completed a 1-page survey regarding goals and priorities for discussion with the oncology team. The survey included 17 potential priorities for discussion in the domains: treatment options, symptom management, emotional concerns, planning for the future, and lifestyle. We evaluated participants’ interest in prioritizing discussion of financial issues and sociodemographic and clinical correlates of this preference. We examined the relationship between desire to discuss financial issues and both distress on the Distress Thermometer (DT) and satisfaction with cancer care using Fisher’s exact test. Results: Among 40 participants, 11 (28%) reported interest in discussing financial issues when making treatment decisions, 29 (72%) were not interested. Average age was 57 (range 31-73), and the majority were white (85%) and college graduates (66%). Only 18% of white patients were interested in addressing cost, while 83% of non-white patients were interested (p < 0.01). Those with a college education were less likely to prioritize financial discussion compared to no college (16% vs. 47%, p = 0.04). Patients interested in discussing cost were more likely to have a household income < $50,000 (50% vs. 22% > $50,000, n.s.) and to have Medicaid (50% vs. 25% other insurance, n.s.). Additionally, patients with higher levels of distress (35% vs. 21% DT < 4, n.s.) and those on novel targeted or biologic therapy (42% vs. 21% other therapy, n.s.) were more likely to prioritize discussion of costs. Desire to discuss cost was not related to satisfaction with care. Conclusions: A substantial minority of patients with MBC, particularly those from less advantaged backgrounds, wish to discuss financial issues at time of treatment decisions. Financial toxicity research should recognize that not all patients desire this discussion and evaluate methods to screen for financial concerns and barriers to care." @default.
• W2947033548 created "2019-06-07" @default.
• W2947033548 creator A5010429902 @default.
• W2947033548 creator A5021894152 @default.
• W2947033548 creator A5029796899 @default.
• W2947033548 creator A5040266917 @default.
• W2947033548 creator A5044012375 @default.
• W2947033548 creator A5065695316 @default.
• W2947033548 creator A5076622630 @default.
• W2947033548 creator A5083365613 @default.
• W2947033548 date "2019-05-20" @default.
• W2947033548 modified "2023-09-27" @default.
• W2947033548 title "Desire to address costs at time of treatment decisions among patients with metastatic breast cancer." @default.
• W2947033548 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.6640" @default.
• W2947033548 hasPublicationYear "2019" @default.
• W2947033548 type Work @default.
• W2947033548 sameAs 2947033548 @default.
• W2947033548 citedByCount "2" @default.
• W2947033548 countsByYear W29470335482020 @default.
• W2947033548 countsByYear W29470335482021 @default.
• W2947033548 crossrefType "journal-article" @default.
• W2947033548 hasAuthorship W2947033548A5010429902 @default.
• W2947033548 hasAuthorship W2947033548A5021894152 @default.
• W2947033548 hasAuthorship W2947033548A5029796899 @default.
• W2947033548 hasAuthorship W2947033548A5040266917 @default.
• W2947033548 hasAuthorship W2947033548A5044012375 @default.
• W2947033548 hasAuthorship W2947033548A5065695316 @default.
• W2947033548 hasAuthorship W2947033548A5076622630 @default.
• W2947033548 hasAuthorship W2947033548A5083365613 @default.
• W2947033548 hasConcept C121608353 @default.
• W2947033548 hasConcept C126322002 @default.
• W2947033548 hasConcept C143998085 @default.
• W2947033548 hasConcept C177713679 @default.
• W2947033548 hasConcept C2775930923 @default.
• W2947033548 hasConcept C530470458 @default.
• W2947033548 hasConcept C71924100 @default.
• W2947033548 hasConceptScore W2947033548C121608353 @default.
• W2947033548 hasConceptScore W2947033548C126322002 @default.
• W2947033548 hasConceptScore W2947033548C143998085 @default.
• W2947033548 hasConceptScore W2947033548C177713679 @default.
• W2947033548 hasConceptScore W2947033548C2775930923 @default.
• W2947033548 hasConceptScore W2947033548C530470458 @default.
• W2947033548 hasConceptScore W2947033548C71924100 @default.
• W2947033548 hasLocation W29470335481 @default.
• W2947033548 hasOpenAccess W2947033548 @default.
• W2947033548 hasPrimaryLocation W29470335481 @default.
• W2947033548 hasRelatedWork W1487320959 @default.
• W2947033548 hasRelatedWork W2106736990 @default.
• W2947033548 hasRelatedWork W2111648462 @default.
• W2947033548 hasRelatedWork W2157333957 @default.
• W2947033548 hasRelatedWork W2170279981 @default.
• W2947033548 hasRelatedWork W2226326221 @default.
• W2947033548 hasRelatedWork W227696832 @default.
• W2947033548 hasRelatedWork W2588058839 @default.
• W2947033548 hasRelatedWork W2597741923 @default.
• W2947033548 hasRelatedWork W2604335154 @default.
• W2947033548 hasRelatedWork W2889559955 @default.
• W2947033548 hasRelatedWork W2890939179 @default.
• W2947033548 hasRelatedWork W2904112399 @default.
• W2947033548 hasRelatedWork W2944429361 @default.
• W2947033548 hasRelatedWork W2966718978 @default.
• W2947033548 hasRelatedWork W2971011457 @default.
• W2947033548 hasRelatedWork W2972334171 @default.
• W2947033548 hasRelatedWork W3046947563 @default.
• W2947033548 hasRelatedWork W764496422 @default.
• W2947033548 hasRelatedWork W2110880400 @default.
• W2947033548 isParatext "false" @default.
• W2947033548 isRetracted "false" @default.
• W2947033548 magId "2947033548" @default.
• W2947033548 workType "article" @default.